Edison Investment Research - Amoeba SA (AMEBA) Amoeba - Focused on high-value opportunities

Report

Edison Investment Research

Toby Thorrington

Amoeba - Focused on high-value opportunities

Amoéba has achieved promising results for the use of its amoeba-based active ingredient in skincare cosmetics in a series of lab and human volunteer trials. In addition, the company secured regulatory approval in the United States and a recommendation for approval in the European Union in 2022 for the active ingredient used in its innovative biological fungicides. Since then, it has tested this active ingredient in standalone and blended use and hopes to achieve product approvals by H125. Amoéba will focus on high-value, high-margin markets in both potential biological fungicide and emerging cosmetic applications.

21/06/2024 1 EN

Underlying

Amoeba SA

Amoeba SA. Amoeba SA is a France-based company that develops, manufactures and markets biological products. The Company specializes in disruptive biological solutions for the treatment of Legionella, amoeba and biofilm in water. The Company's offering includes products and services, such as: Cleantech biological solution, a patented technological disruptive product with no impact on the environment; amoebic analyses of waters of wet cooling towers (TAR), hot sanitary waters, industrial waters and waters of swimming pools; as well as Legionella tests of industrial waste water, among others. The Company is engaged in various technical, commercial, industrial and investment partnerships.

See profile

FR0011051598 Euronext Paris France

Provider

Edison Investment Research

Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisors and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting.

See profile

Analysts

Toby Thorrington

Other Reports on these Companies

EQS Group AG

Edison issues report on Amoéba (ALMIB)

Edison Investment Research Limited Edison issues report on Amoéba (ALMIB) 21-Jun-2024 / 12:36 GMT/BST The issuer is solely responsible for the content of this announcement. London, UK, 21 Juni 2024 Edison issues report on Amoéba (ALMIB) to view the full report. All reports published by Edison are available to download free of charge from its website Edison is authorised and regulated by the . Edison is not an adviser or broker-dealer and does not provide investment advice. Edison’s reports are not solicitations to buy or sell any securities. For more information, p...

June 21, 2024 June 21, 2024 1 EN

Edison Investment Research

Amoeba - Biocontrol plant paves path to commercialisation

Thus far, FY23 has marked a year of successful advancement for Amoéba: (1) the development of its biocontrol plant is ongoing, poised to achieve production of 40 tonnes per annum of W. magna lysate; (2) a third scientific article has been published, which highlights the efficacy of its biocontrol product; and (3) the company has announced a potential further application for W. magna lysate in cosmetic skincare. The new application will not hinder advancement of the biological fungicide product. H123 saw the widening of EBIT losses by €1.0m y-o-y to €3.9m, primarily attributable to increased in...

November 16, 2023 November 16, 2023 1 EN

Pan African Resources - Analysing H224 and looking forward to FY25

Pan African Resources’ (PAF’s) FY24 results, announced on 11 September, were within 1% of our prior forecasts for both EPS (4.14c cf 4.17c) and headline EPS (HEPS; 4.15c cf 4.17c). However, if the contract liability related to its ZAR400m financing facility for Mintails is stripped out, we calculate that PAF would have recorded HEPS of 5.27c, which would have been close to the top of the range of analysts’ expectations and also a record for both 12-month and six-month periods. While arguably academic for FY24, this nevertheless sets the stage for more material EPS and cash flow increases in th...

September 27, 2024 September 27, 2024 1 EN

Toby Thorrington

Toby Thorrington

Greencoat Renewables - Efficient capital allocation and increasing demand

Greencoat Renewables’ (GRP’s) large and diversified pan-European portfolio of renewable energy assets generated net cash of €113.6m in H124 (H123: €125.5m). This equated to gross dividend cover of 3x at end-H124 and a six-month return of 8.6% on its December 2023 net asset value (NAV). NAV per share remained flat at 112.1c, due to less impactful power price movements in the period and strong cash generation offsetting depreciation and dividend payments. GRP’s weighted average cost of debt reduced from 3.3% to 3.1%, due to terming out of a more expensive RCF debt and refinancing a new €150m fiv...

September 26, 2024 September 26, 2024 1 EN

Pedro Fonseca

Pedro Fonseca

Henderson International Income Trust - Buying into the rapid spread of technology

Henderson International Income Trust (HINT) seeks out companies with potential for growth from exposure to structural themes that is not priced into their valuations. The trust’s manager, Ben Lofthouse, believes the market’s current narrow focus on a few AI-related stocks means now is an especially good time to find such undervalued businesses. He has taken this opportunity to acquire companies with exposure to the rapid spread of technology and related themes, including several Asian businesses. Recent performance has improved thanks to these acquisitions, ensuring the trust continues to meet...

September 26, 2024 September 26, 2024 1 EN

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN

Amoeba - Focused on high-value opportunities

Edison issues report on Amoéba (ALMIB)

Amoeba - Biocontrol plant paves path to commercialisation

Pan African Resources - Analysing H224 and looking forward to FY25

Greencoat Renewables - Efficient capital allocation and increasing demand

Henderson International Income Trust - Buying into the rapid spread of technology

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

Sign-up for free to access full reports immediately

ResearchPool Subscriptions

Get the most out of your insights

Why subscribe?

How to subscribe

ResearchPool Subscriptions

This report is only available to subscribers

Why subscribe?

How to subscribe